http://www.zibb.com/all/theme/cq/Pfizer+Incorporated Zibb. The Global business search engine. en-US search@zibb.com (RB Search)Copyright (c) 2007 Reed Business Information. All rights reserved.Wed, 25 Nov 2009 21:40:36 GMTWed, 25 Nov 2009 21:40:36 GMT608831http://www.zibb.com/all/theme/cq/Pfizer+Incorporated http://www.zibb.com/images/en/g_zibb_logo_beta.gif http://www.cognos.com/dk/events/presentations.htmlCognos is a world leader in business intelligence, corporate performance management, data integration, enterprise risk management, olap reporting, analytics software, Oracle business intelligence, and balanced scorecarding for the enterprise.http://www.cognos.com/dk/events/presentations.htmlPfizer Incorporatedhttp://www.researchandmarkets.com/reports/301740/event_analysis_and_response_service_cox_2s.pdfDescription: On 30th September 2004, Merck withdrew its blockbuster drug Vioxx from the global market after trial data reinforced the suspicion that it increased the risk of cardiovascular events. Vioxx was a widely used Cox-2 selective non-steroidal anti-inflammatory drug.http://www.researchandmarkets.com/reports/301740/event_analysis_and_response_service_cox_2s.pdfPfizer Incorporatedhttp://www.aginfo.com/index.cfm/event/report/id/Product-Reviews-12816Pfizer Animal Genetics has made new advancements in Arthrogryposis Multiplex (AM) diagnostics to improve its testing capacity. Investments in equipment and an improved testing methodology enable Pfizer to run larger numbers of samples more efficiently.http://www.aginfo.com/index.cfm/event/report/id/Product-Reviews-12816Pfizer Incorporatedhttp://www-03.ibm.com/industries/healthcare/us/detail/event/M508118Q25841B49.htmlLearn how leading researchers in the pharmaceutical/biotech and chemicals/materials fields are applying computational solutions for modeling and simulation, informatics, and data integration and reporting.http://www-03.ibm.com/industries/healthcare/us/detail/event/M508118Q25841B49.htmlPfizer Incorporatedhttp://www.ispe.org/cs/root/education_and_training/events/2008_washington_conferences/speaker_biography?speakerID=295032Holger Weyhers, PhD, is Director Production of Pfizer Manufacturing Deutschland GmbH. Weyhers joined Pfizer Germany in 1996 as a management trainee. In 1997 he relocated to the US to spend a year at Pfizer New York Headquarters in the new products group of global manufacturing services.http://www.ispe.org/cs/root/education_and_training/events/2008_washington_conferences/speaker_biography?speakerID=295032Pfizer Incorporatedhttp://www.economistconferences.com/Roundtable/Public/con_common.asp?spkID=12437&rtID=1229&area=13&rtRegion=1&pgRegion=&preview=Dr Mak Jawadekar is currently a Director, Portfolio Management & Performance Group which is part of WWPPM division within Development Operations in PGRD, Groton-New London.http://www.economistconferences.com/Roundtable/Public/con_common.asp?spkID=12437&rtID=1229&area=13&rtRegion=1&pgRegion=&preview=Pfizer Incorporatedhttp://www.economistconferences.com/Roundtable/Public/con_common.asp?spkID=9759&rtID=1041&area=13&rtRegion=4&pgRegion=&preview=Kewal Handa Managing Director Pfizer India Kewal Handa is Managing Director of Pfizer India, the world’s leading pharmaceutical company. Under his leadership, the company is now aggressive in its growth plans and has launched several new products. Mr Handa joined Pfizer 16 years ago.http://www.economistconferences.com/Roundtable/Public/con_common.asp?spkID=9759&rtID=1041&area=13&rtRegion=4&pgRegion=&preview=Pfizer Incorporated